Pillstats
Rx only · Injection, Solution, Concentrate · Intravenous

Dobutamine

Dobutamine Hydrochloride

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC01CA07
RxCUI (US)3616
US makers2 labelers
Packages5
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2675348011.1K2025 Q12025 Q22025 Q32025 Q42026 Q1
254
Rx · 2026 Q1
27K
Units dispensed
-73%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Hospira, Inc.unknown3SUPPLYING
HF Acquisition Co LLC, DBA HealthFirstunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Aug 27, 2025
    RESOLVEDShortage resolved: Dobutamine Hydrochloride Injection (Pfizer Inc.)

    Dobutamine Hydrochloride Injection — reported in shortage by Pfizer Inc.. Therapeutic category: Cardiovascular, Pediatric, Renal.

  • Aug 27, 2025
    SHORTAGEDrug shortage: Dobutamine Hydrochloride Injection (Pfizer Inc.)

    Dobutamine Hydrochloride Injection — reported in shortage by Pfizer Inc.. Therapeutic category: Cardiovascular, Pediatric, Renal.

  • May 28, 2025
    RECALLRecall (Class II): DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, …

    Discoloration; discolored solution from cracked vials — Recalling firm: Pfizer Inc. — Nationwide in the USA

  • Nov 6, 2017
    SHORTAGEDrug shortage: Dobutamine Hydrochloride Injection (Hospira, Inc., a Pfizer Company)

    Dobutamine Hydrochloride Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Cardiovascular, Pediatric, Renal.

  • Jan 10, 2014
    RECALLRecall (Class I): DOBUTamine Injection, USP, 250 mg per 20 mL, 20 mL Single-dose Fliptop Vial, Rx only, Manufactured for Hospira Inc., La…

    Presence of Particulate Matter: Discolored solution due to a chip in the glass at the neck of the vial, also glass particulate was found within the solution. — Recalling firm: Hospira Inc. — Nationwide and Puerto Rico.